{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:57:41Z","timestamp":1792684661952,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":394,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jacc.2025.07.026","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T22:55:11Z","timestamp":1758581711000},"page":"982-995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association Between Anticoagulant Therapy and Survival in Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8214-3010","authenticated-orcid":false,"given":"Laurent","family":"Bertoletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7348-418X","authenticated-orcid":false,"given":"Jean","family":"Escal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ath\u00e9na\u00efs","family":"Boucly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9gol\u00e8ne","family":"Turquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitja","family":"Jevnikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Lamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7900-8245","authenticated-orcid":false,"given":"Souad","family":"Bezzeghoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Chapelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Delavenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Savale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-6922","authenticated-orcid":false,"given":"David","family":"Montani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Sitbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Jais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jacc.2025.07.026_bib1","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1183\/09031936.06.00015206","article-title":"Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review","volume":"28","author":"Johnson","year":"2006","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jacc.2025.07.026_bib2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0012-3692(15)51873-4","article-title":"Thrombotic arteriopathy and anticoagulation in pulmonary hypertension","volume":"130","author":"Johnson","year":"2006","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.jacc.2025.07.026_bib3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1164\/ajrccm.150.4.7921465","article-title":"Fibrinogen, t-PA, and PAI-1 plasma levels in patients with pulmonary hypertension","volume":"150","author":"Huber","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.jacc.2025.07.026_bib4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.CIR.70.4.580","article-title":"Primary pulmonary hypertension: natural history and the importance of thrombosis","volume":"70","author":"Fuster","year":"1984","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacc.2025.07.026_bib5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.07.026_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2024.101240","article-title":"Tailoring oral anticoagulant treatment in the era of multi-drug therapies for PAH and CTEPH","volume":"68","author":"Escal","year":"2024","journal-title":"Blood Rev"},{"issue":"20","key":"10.1016\/j.jacc.2025.07.026_bib7","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacc.2025.07.026_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacc.2025.07.026_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.jacc.2025.07.026_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/CIRCULATIONAHA.113.004526","article-title":"Anticoagulation and survival in pulmonary arterial hypertension: results from the comparative, prospective registry of newly initiated therapies for pulmonary hypertension (COMPERA)","volume":"129","author":"Olsson","year":"2014","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.jacc.2025.07.026_bib11","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1161\/CIRCULATIONAHA.115.018435","article-title":"Effect of warfarin treatment on survival of patients with pulmonary arterial hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)","volume":"132","author":"Preston","year":"2015","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacc.2025.07.026_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar4051","article-title":"Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study","volume":"14","author":"Ngian","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.jacc.2025.07.026_bib13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13075-017-1341-x","article-title":"Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension","volume":"19","author":"Morrisroe","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.jacc.2025.07.026_bib14","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.healun.2022.08.019","article-title":"Anticoagulation in pulmonary arterial hypertension\u2014association with mortality, healthcare utilization, and quality of life: the Pulmonary Hypertension Association Registry (PHAR)","volume":"41","author":"Garry","year":"2022","journal-title":"J Heart Lung Transplant"},{"issue":"9","key":"10.1016\/j.jacc.2025.07.026_bib15","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.jacc.2025.07.026_bib16","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1183\/09031936.00116313","article-title":"Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study","volume":"43","author":"Sitbon","year":"2014","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.jacc.2025.07.026_bib17","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1164\/rccm.202009-3698OC","article-title":"Association between initial treatment strategy and long-term survival in pulmonary arterial hypertension","volume":"204","author":"Boucly","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.jacc.2025.07.026_bib18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1183\/09031936.00057010","article-title":"Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension","volume":"36","author":"Humbert","year":"2010","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.jacc.2025.07.026_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/aje\/kwn135","article-title":"Immeasurable time bias in observational studies of drug effects on mortality","volume":"168","author":"Suissa","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.jacc.2025.07.026_bib20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/jama.2019.21558","article-title":"Using propensity score methods to create target populations in observational clinical research","volume":"323","author":"Thomas","year":"2020","journal-title":"JAMA"},{"issue":"28","key":"10.1016\/j.jacc.2025.07.026_bib21","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.jacc.2025.07.026_bib22","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2024"},{"issue":"25","key":"10.1016\/j.jacc.2025.07.026_bib23","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1161\/CIRCULATIONAHA.110.015693","article-title":"Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT","volume":"123","author":"Kawut","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jacc.2025.07.026_bib24","first-page":"307","article-title":"Risk of direct oral anticoagulant bioaccumulation in patients with pulmonary hypertension","volume":"91","author":"Gabriel","year":"2016","journal-title":"Respir Int Rev Thorac Dis"},{"key":"10.1016\/j.jacc.2025.07.026_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.amjcard.2023.11.050","article-title":"Hospital outcomes in patients with pulmonary hypertension with atrial fibrillation in the United States","volume":"212","author":"Rubens","year":"2024","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.jacc.2025.07.026_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107247","article-title":"Pulmonary hypertension: an unexplored risk factor for stroke in patients with atrial fibrillation","volume":"32","author":"Khattar","year":"2023","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jacc.2025.07.026_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.113.007143","article-title":"Letter by Bertoletti et al regarding article, \u201cAnticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).\u201d","volume":"130","author":"Bertoletti","year":"2014","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jacc.2025.07.026_bib28","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1183\/09031936.00039212","article-title":"Major bleeding with vitamin K antagonist anticoagulants in pulmonary hypertension","volume":"41","author":"Henkens","year":"2013","journal-title":"Eur Respir J"},{"issue":"67","key":"10.1016\/j.jacc.2025.07.026_bib29","article-title":"Bleeding under anticoagulant therapy in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: preliminary results from the HEMA-HTP study","volume":"62","author":"Bezzeghoud","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2025.07.026_bib30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jclinepi.2020.04.006","article-title":"Early detection of the existence or absence of the treatment effect: a cumulative meta-analysis","volume":"124","author":"Laporte","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jacc.2025.07.026_bib31","article-title":"Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey","volume":"352","author":"Hemkens","year":"2016","journal-title":"BMJ"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725072493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725072493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:49:22Z","timestamp":1790729362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109725072493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":31,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0735109725072493"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2025.07.026","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Anticoagulant Therapy and Survival in Pulmonary Arterial Hypertension","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2025.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}